Clinical Scorecard: Intraocular Pressure Dysregulation Symptoms Associated with Clopidogrel Treatment Following Patent Foramen Ovale Closure in a Patient with Ocular Hypertension and Angle Crowding: A Case Study

At a Glance

Key Highlights

• Clopidogrel may cause recurrent ocular symptoms in patients with ocular hypertension.
• Symptoms improved after clopidogrel withdrawal and recurred upon re-administration.
• 24-h IOP monitoring showed significant peak elevation and diurnal fluctuation during clopidogrel exposure.
• Baseline IOP measurements indicated ocular hypertension without glaucomatous damage.
• This case suggests a temporal association rather than definitive evidence of drug-induced effects.

Guideline-Based Recommendations

Diagnosis

• Monitor intraocular pressure in patients with ocular hypertension on clopidogrel.

Management

• Consider discontinuation of clopidogrel in patients experiencing ocular symptoms.

Monitoring & Follow-up

• Conduct 24-h IOP monitoring in patients with known ocular hypertension on antiplatelet therapy.

Risks

• Increased risk of intraocular pressure elevation and potential glaucoma onset.

Patient & Prescribing Data

52-year-old woman with ocular hypertension and angle crowding.

Clopidogrel may exacerbate ocular symptoms and IOP dysregulation.

Clinical Best Practices

• Perform thorough ophthalmic assessments prior to initiating clopidogrel in at-risk patients.
• Document baseline IOP measurements and monitor for changes during clopidogrel therapy.

Related Resources & Content

• Case Study